6-111580262-G-T

Variant summary

Our verdict is Benign. The variant received -14 ACMG points: 0P and 14B. BP4_StrongBP6_ModerateBS1BS2

The NM_147686.4(TRAF3IP2):​c.957C>A​(p.Ser319Arg) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0013 in 1,613,054 control chromosomes in the GnomAD database, including 11 homozygotes. In-silico tool predicts a benign outcome for this variant. 14/22 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★).

Frequency

Genomes: 𝑓 0.0012 ( 1 hom., cov: 33)
Exomes 𝑓: 0.0013 ( 10 hom. )

Consequence

TRAF3IP2
NM_147686.4 missense

Scores

5
14

Clinical Significance

Benign criteria provided, single submitter B:2

Conservation

PhyloP100: 0.252

Publications

5 publications found
Variant links:
Genes affected
TRAF3IP2 (HGNC:1343): (TRAF3 interacting protein 2) This gene encodes a protein involved in regulating responses to cytokines by members of the Rel/NF-kappaB transcription factor family. These factors play a central role in innate immunity in response to pathogens, inflammatory signals and stress. This gene product interacts with TRAF proteins (tumor necrosis factor receptor-associated factors) and either I-kappaB kinase or MAP kinase to activate either NF-kappaB or Jun kinase. Several alternative transcripts encoding different isoforms have been identified. Another transcript, which does not encode a protein and is transcribed in the opposite orientation, has been identified. Overexpression of this transcript has been shown to reduce expression of at least one of the protein encoding transcripts, suggesting it has a regulatory role in the expression of this gene. [provided by RefSeq, Aug 2009]
TRAF3IP2-AS1 (HGNC:40005): (TRAF3IP2 antisense RNA 1)

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -14 ACMG points.

BP4
Computational evidence support a benign effect (MetaRNN=0.007829368).
BP6
Variant 6-111580262-G-T is Benign according to our data. Variant chr6-111580262-G-T is described in ClinVar as Benign. ClinVar VariationId is 541101.Status of the report is criteria_provided_single_submitter, 1 stars.
BS1
Variant frequency is greater than expected in population sas. GnomAd4 allele frequency = 0.00118 (179/152336) while in subpopulation SAS AF = 0.00518 (25/4828). AF 95% confidence interval is 0.0036. There are 1 homozygotes in GnomAd4. There are 87 alleles in the male GnomAd4 subpopulation. Median coverage is 33. This position passed quality control check.
BS2
High Homozygotes in GnomAdExome4 at 10 AR,AD gene

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
TRAF3IP2NM_147686.4 linkc.957C>A p.Ser319Arg missense_variant Exon 3 of 9 ENST00000368761.11 NP_679211.2 O43734-2

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
TRAF3IP2ENST00000368761.11 linkc.957C>A p.Ser319Arg missense_variant Exon 3 of 9 1 NM_147686.4 ENSP00000357750.5 O43734-2

Frequencies

GnomAD3 genomes
AF:
0.00118
AC:
179
AN:
152218
Hom.:
1
Cov.:
33
show subpopulations
Gnomad AFR
AF:
0.0000965
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.000458
Gnomad ASJ
AF:
0.0161
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.00517
Gnomad FIN
AF:
0.00
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.00115
Gnomad OTH
AF:
0.00430
GnomAD2 exomes
AF:
0.00177
AC:
445
AN:
250766
AF XY:
0.00191
show subpopulations
Gnomad AFR exome
AF:
0.00
Gnomad AMR exome
AF:
0.000492
Gnomad ASJ exome
AF:
0.0159
Gnomad EAS exome
AF:
0.00
Gnomad FIN exome
AF:
0.000139
Gnomad NFE exome
AF:
0.00122
Gnomad OTH exome
AF:
0.00262
GnomAD4 exome
AF:
0.00131
AC:
1912
AN:
1460718
Hom.:
10
Cov.:
34
AF XY:
0.00144
AC XY:
1048
AN XY:
726692
show subpopulations
African (AFR)
AF:
0.0000598
AC:
2
AN:
33434
American (AMR)
AF:
0.000425
AC:
19
AN:
44704
Ashkenazi Jewish (ASJ)
AF:
0.0169
AC:
441
AN:
26118
East Asian (EAS)
AF:
0.00
AC:
0
AN:
39668
South Asian (SAS)
AF:
0.00413
AC:
356
AN:
86230
European-Finnish (FIN)
AF:
0.000187
AC:
10
AN:
53408
Middle Eastern (MID)
AF:
0.00868
AC:
50
AN:
5762
European-Non Finnish (NFE)
AF:
0.000806
AC:
895
AN:
1111036
Other (OTH)
AF:
0.00230
AC:
139
AN:
60358
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.465
Heterozygous variant carriers
0
102
204
305
407
509
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
34
68
102
136
170
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.00118
AC:
179
AN:
152336
Hom.:
1
Cov.:
33
AF XY:
0.00117
AC XY:
87
AN XY:
74490
show subpopulations
African (AFR)
AF:
0.0000962
AC:
4
AN:
41580
American (AMR)
AF:
0.000457
AC:
7
AN:
15304
Ashkenazi Jewish (ASJ)
AF:
0.0161
AC:
56
AN:
3472
East Asian (EAS)
AF:
0.00
AC:
0
AN:
5178
South Asian (SAS)
AF:
0.00518
AC:
25
AN:
4828
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
10618
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
294
European-Non Finnish (NFE)
AF:
0.00115
AC:
78
AN:
68034
Other (OTH)
AF:
0.00425
AC:
9
AN:
2116
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.493
Heterozygous variant carriers
0
11
23
34
46
57
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
4
8
12
16
20
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.00153
Hom.:
1
Bravo
AF:
0.00108
TwinsUK
AF:
0.000809
AC:
3
ALSPAC
AF:
0.00156
AC:
6
ESP6500AA
AF:
0.00
AC:
0
ESP6500EA
AF:
0.00163
AC:
14
ExAC
AF:
0.00182
AC:
221
EpiCase
AF:
0.00213
EpiControl
AF:
0.00213

ClinVar

Significance: Benign
Submissions summary: Benign:2
Revision: criteria provided, single submitter
LINK: link

Submissions by phenotype

Candidiasis, familial, 8 Benign:1
Feb 03, 2025
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

TRAF3IP2-related disorder Benign:1
Sep 13, 2019
PreventionGenetics, part of Exact Sciences
Significance:Benign
Review Status:no assertion criteria provided
Collection Method:clinical testing

This variant is classified as benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.24
BayesDel_addAF
Benign
-0.37
T
BayesDel_noAF
Benign
-0.31
CADD
Benign
20
DANN
Uncertain
1.0
DEOGEN2
Benign
0.14
.;.;T;T
Eigen
Benign
0.14
Eigen_PC
Benign
0.14
FATHMM_MKL
Uncertain
0.76
D
LIST_S2
Benign
0.62
T;T;.;T
M_CAP
Benign
0.011
T
MetaRNN
Benign
0.0078
T;T;T;T
MetaSVM
Benign
-1.1
T
MutationAssessor
Uncertain
2.4
.;.;M;M
PhyloP100
0.25
PrimateAI
Benign
0.37
T
PROVEAN
Benign
-1.3
N;N;N;.
REVEL
Benign
0.11
Sift
Uncertain
0.010
D;D;D;.
Sift4G
Uncertain
0.044
D;D;D;D
Polyphen
0.94
P;.;P;P
Vest4
0.27
MutPred
0.37
.;.;Gain of MoRF binding (P = 0.0245);Gain of MoRF binding (P = 0.0245);
MVP
0.56
MPC
0.25
ClinPred
0.051
T
GERP RS
1.8
Varity_R
0.066
gMVP
0.38
Mutation Taster
=92/8
polymorphism

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs146226365; hg19: chr6-111901465; API